Statistics for Eterna Therapeutics (id:6070 ERNA)
Valuation metrics
Market cap
31.58M
Enterprise value
51.71M
Trailing P/E (ttm)
-0.12
Forward P/E
-0.06
PEG ratio
-0.06
Price/Sales (ttm)
194.94
Price/Book (mrq)
1.49
Enterprise Value/Revenue
319.17
Enterprise Value/EBITDA
-2.36
Overview
Shares outstanding
51.37M
Float
3.28M
Shares short
44.46K
% Held by insiders
3.36%
% Held by institutions
0.11%
Average volume (10 days)
217.13K
Average volume (90 days)
Price summary
52-Week low
0.46
52-Week high
2.63
52-Week change
-104.26%
Beta
7.77
50-Day moving average
1.09
200-Day moving average
1.72
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
October 17th, 2022
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-247.06%
Operating margin
-10,491.49%
Operational effectiveness
Return on assets
-29.42%
Return on equity
-971.07%
Income statement
Revenue (ttm)
0.03
Revenue per share (ttm)
0.03
Quarterly revenue growth (yoy)
Gross profit (ttm)
-168,000.00
EBITDA
-21,863,000.00
Net income to common (ttm)
-23,936,000.00
Diluted EPS (ttm)
-8.31
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
2.59M
Total cash per share (mrq)
0.48
Total debt (mrq)
49.20M
Total Debt/Equity (mrq)
-1.08
Current ratio (mrq)
37.30%
Book value per share (mrq)
0.41
Cash flow
Cash flow statement
-16,493,000.00
Levered free cash flow (LFCF)
-11,775,750.00